Rashmi Virendra Ramchandani - 20 Jan 2026 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: VP, Chief Accounting Officer
Signature: /s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 20 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 22 Jan 2026, 18:12:07 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ramchandani Rashmi Virendra	VP, Chief Accounting Officer	C/O BIOMARIN PHARMACEUTICAL, 770 LINDARO STREEET, SAN RAFAEL	/s/ Tae Sang Yoo, Attorney-in-Fact	22 Jan 2026	0002106034

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Award	$0	+18,540		$0.000000	18,540	20 Jan 2026	Direct	F1
transaction	BMRN	Common Stock	Award	$0	+7,070	+38%	$0.000000	25,610	20 Jan 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to Buy Common Stock)	Award	$0	+18,220		$0.000000	18,220	20 Jan 2026	Common Stock	18,220	$56.31	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on January 20, 2026. Price not applicable.
F2	Option grant vests 12/48th on January 20, 2027 and 1/48th on the 20th day of each month thereafter.